ACHV Stock Summary and Trading Ideas (Achieve Life Sciences - Common Shares | NASDAQ:ACHV)

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Achieve Life Sciences - Common Shares trades on the NASDAQ stock market under the symbol ACHV.

As of April 19, 2024, ACHV stock price declined to $4.52 with 11,734 million shares trading.

ACHV has a beta of 0.57, meaning it tends to be less sensitive to market movements. ACHV has a correlation of 0.01 to the broad based SPY ETF.

ACHV has a market cap of $154.82 million. This is considered a Micro Cap stock.

In the last 3 years, ACHV stock traded as high as $11.75 and as low as $2.00.

The top ETF exchange traded funds that ACHV belongs to (by Net Assets): VTI, VXF.

ACHV stock has underperformed the market in the last year with a return of -38.8%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ACHV shares. However, ACHV has outperformed the market in the last 3 month and 2 week periods, returning +5.1% and +0.9%, while SPY returned +4.3% and -3.5%, respectively. This indicates ACHV has been having a stronger performance recently.

ACHV support price is $4.43 and resistance is $4.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHV stock will trade within this expected range on the day.